| CAT No: | CL-OZX-03 |
| CAS No: | NA |
| Mol.F: | C28H25N3O4 |
| Mol.Wt.: | 467.5 |
| Chemical Name: | 1-Cyclopropyl-8-methyl-7-(5-methyl-6-(N-methylbenzamido)pyridin-3-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| Inventory Status: | Custom synthesis |
This impurity is related to Ozenoxacin Impurity 1 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Ozenoxacin Impurity 1 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:1-Cyclopropyl-8-methyl-7-(5-methyl-6-(N-methylbenzamido)pyridin-3-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acidCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Ozenoxacin Molecular Formula: C28H25N3O4
Molecular Weight: 467.5
Storage: Store in a cool, dry place.
| Product Name: | Ozenoxacin Impurity 1 |
| CAS No: | |
| Mol.F.: | C28H25N3O4 |
| Mol.Wt.: | 467.5 |
Cat. No: CL-OZX-NO-01
CAS No: NA
Mol. F: C18H16N4O4
Mol. Wt: 352.16
Inv. Status: Custom Synthesis
Cat. No: CL-OZX-NO-02
CAS No: NA
Mol. F: C29H29N7O7
Mol. Wt: 587.58
Inv. Status: Custom Synthesis
Cat. No: CL-OZX-NO-03
CAS No: NA
Mol. F: C15H19N3O7
Mol. Wt: 353.3
Inv. Status: Custom Synthesis
Cat. No: CL-OZX-01
CAS No: 245765-41-7
Mol. F: C21H21N3O3
Mol. Wt: 363.4
Inv. Status: Custom Synthesis
Cat. No: CL-OZX-02
CAS No: 446299-90-7
Mol. F: C30H29N3O4
Mol. Wt: 495.6
Inv. Status: Custom Synthesis
Cat. No: CL-OZX-04
CAS No: NA
Mol. F: C21H18D3N3O3
Mol. Wt: 366.4
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: